Get started
Work

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

Year: 2015
Type: article
Study design: Clinical Trial
DOI: 10.1093/annonc/mdv537
Authors: S.J. Wong, T. Karrison, D.N. Hayes, M.S. Kies, K.J. Cullen, T. Tanvetyanon, A. Argiris, N. Takebe, D. Lim, N.F. Saba, F.P. Worden, J. Gilbert, H.J. Lenz, A.R.A. Razak, J.D. Roberts, E.E. Vokes, E.E.W. Cohen
Institutions: Medical College of Wisconsin, University of Chicago, University of North Carolina at Chapel Hill, The University of Texas MD Anderson Cancer Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Moffitt Cancer Center, The University of Texas at San Antonio Health Science Center, Hygeia Hospital, City Of Hope National Medical Center, City of Hope, Emory University, Winship Cancer Institute, University of Michigan, U-M Rogel Cancer Center, Vanderbilt University, USC Norris Comprehensive Cancer Center, Princess Margaret Cancer Centre, VCU Massey Comprehensive Cancer Center, University of California San Diego, Moores Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2178274441
FWCI: 5.447
Cites: 18
Cited by: 94
Related to: 10